other material
confidence high
sentiment neutral
materiality 0.40
Aprea Therapeutics enters ATM equity offering agreement for up to $3.0M with H.C. Wainwright
Aprea Therapeutics, Inc.
- Aprea entered into an at-the-market offering agreement with H.C. Wainwright to sell up to $3.0M of common stock.
- HCW will serve as sales agent and receive a 3.0% commission on gross proceeds from sales.
- Net proceeds will fund general corporate purposes, including preclinical studies and clinical trials.
- The company is not obligated to sell any shares under the agreement; sales may occur from time to time.